AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
BRINZOLAMIDE
23 registrations across 11 African markets— 20 active
Markets with BRINZOLAMIDE
🇺🇬Uganda
4 registrations
4 active
🇿🇦South Africa
4 registrations
4 active
🇲🇬Madagascar
4 registrations
4 active
🇨🇮Côte d'Ivoire
2 registrations
1 active
🇸🇳Senegal
2 registrations
2 active
🇹🇿Tanzania
2 registrations
2 active
🇹🇳Tunisia
1 registration
0 active
🇿🇼Zimbabwe
1 registration
1 active
🇲🇼Malawi
1 registration
0 active
🇳🇬Nigeria
1 registration
1 active
🇲🇦Morocco
1 registration
1 active
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| AZIBRIN 1 % | 🇿🇦South Africa | Ranbaxy (SA) (Pty) Ltd | active | Jan 2029 |
| Azopt Eye Drops** Suspension/Drops | 🇳🇬Nigeria | Novartis Nigeria Limited | active | Dec 2028 |
| BRINZOLAMIDE BIOGARAN 10MG/ML COLLYRE EN SUSPENSION FLACON DE 5ML | 🇨🇮Côte d'Ivoire | BIOGARAN | active | Apr 2028 |
| AZOPT SUSPENSION/DROPS; OPHTHALMIC | 🇿🇼Zimbabwe | NOVARTIS PHARMA SERVICES AG | active | Dec 2027 |
| AZOPT 10MG/1ML COLLYRE EN SUSPENSION FLACON DE 5ML | 🇨🇮Côte d'Ivoire | NOVARTIS COTE D'IVOIRESASU | expired | Apr 2024 |
| AZOPT 10MG/ML EYE SUSPENSION EYE SUSPENSION | 🇲🇼Malawi | — | expired | Mar 2024 |
| AZOPT Collyre / 1% | 🇹🇳Tunisia | NOVARTIS EUROPHARM LIMITED IRLANDE | expired | Nov 2018 |
| AZARGA | 🇿🇦South Africa | Novartis South Africa (Pty) Ltd | active | Jan 1900 |
| AZOPTIC | 🇿🇦South Africa | Novartis South Africa (Pty) Ltd | active | Jan 1900 |
| OCURINZ | 🇿🇦South Africa | Pharma Dynamics (Pty) Ltd | active | Jan 1900 |
| brinzox Opthalmic Suspension | 🇹🇿Tanzania | Ajanta Pharma Limited | active | — |
| BRINZOLAMIDE OPHTHALMIC
SUSPENSIONS | 🇺🇬Uganda | AJANTA PHARMA LIMTED | active | — |
| AZOPT® 10MG/ML COLLY BTE(1FL X 5ML) NOVARTIS EUROPHARM Collyre en suspension, boîte d' | 🇲🇬Madagascar | NOVARTIS EUROPHARM LIMITED | active | — |
| AZOPT COLLYRE | 🇲🇦Morocco | — | active | — |
| AZOPT collyre / 10 mg / ml | 🇸🇳Senegal | ALCON FRANCE | active | — |
| AZOPT® 10MG/ML COLLY BTE(1F X 5ML) NOVARTIS Collyre en suspension, boîte d' | 🇲🇬Madagascar | NOVARTIS EUROPHARM LIMITED | active | — |
| AZOPT® 10MG/ML COLLY BTE(1FL X 5ML) NOVARTIS EUROPHARM Collyre en suspension, boîte d' | 🇲🇬Madagascar | NOVARTIS EUROPHARM LIMITED | active | — |
| Azopt Opthalmic Suspension | 🇹🇿Tanzania | NVS Kenya Limited | active | — |
| BRINZOLAMIDE OPHTHALMIC
SUSPENSIONS | 🇺🇬Uganda | AJANTA PHARMA LIMTED | active | — |
| AZOPT® 10MG/ML COLLY BTE(1F X 5ML) NOVARTIS Collyre en suspension, boîte d' | 🇲🇬Madagascar | NOVARTIS EUROPHARM LIMITED | active | — |
| BRINZOLAMIDE OPHTHALMIC
SUSPENSIONS | 🇺🇬Uganda | NORVATIS PHARMA AG- SWITZERLAND | active | — |
| SIMBRINZA collyre / 10 mg | 🇸🇳Senegal | NOVARTIS SERVICES AG | active | — |
| BRINZOLAMIDE OPHTHALMIC
SUSPENSIONS | 🇺🇬Uganda | NORVATIS PHARMA AG- SWITZERLAND | active | — |
BRINZOLAMIDE in Africa — Regulatory Overview
BRINZOLAMIDE is registered across 11 African markets with 23 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Uganda, South Africa, Madagascar, Côte d'Ivoire and 7 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 23 registrations, 20 (87%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.